Read these maps that illustrate Hep B and Hep C burden by NYC Council District, 2014-2015.
Watch and share this new video about prescription medication misuse and Hep C risk among young people in Staten Island.
This wallet-sized pocket card from the NYC Health Department provides ten health tips on Hep C prevention, testing, care and treatment.
The NYC Department of Health implemented a patient navigation program, Check Hep C, to address patient and provider barriers to HCV care and potentially lifesaving treatment.
The report takes a comprehensive look at the problem of addiction and summarizes what we know about substance misuse, highlighting what works in prevention, treatment, and recovery.
This report presents an overview of the New York City Health Department’s 2015 surveillance and research data on hepatitis B and C in NYC, as well as the Health Department’s programmatic activities to address these epidemics.
The report presents data on Hep C in syringe exchange programs in NYC.
The Mission of the Viral Hepatitis Strategic Plan is to outline a systematic approach that will decrease the incidence and reduce the morbidity and mortality of viral hepatitis.
Check out the Hep Free NYC 2015 Annual Report to read about all the exciting events that took place in 2015!
The New York City Department of Health and Mental Hygiene conducted an enhanced surveillance project to better understand the reasons patients are not treated for HCV.
The Hep Free NYC LGBTQ Working Group has created a Hepatitis Resource Card for the Lesbian, Gay, Bisexual, Transgender, and Queer community.
The study concludes that the high burden of Hep B infection among African immigrants in the United States underscores a need for continued screening and linkage to care in this at-risk population.
World Health Organization issued updated guidelines for screening, care, and treatment of chronic Hep C.
In March 2016, HHS issued guidance for HHS-funded programs regarding the use of federal funds to implement or expand syringe services programs for people who inject drugs.
The CDC and HHS Report states that Hep B and C could both be eliminated as public health problems in the U.S. but would take considerable will and resources.
BE ABOUT IT is the story of two fathers, two families and their battle against a potentially deadly disease impacting the Asian American community
A new Epi Data Brief Neighborhood Poverty and Infectious Diseases: Health Disparities in NYC found that New Yorkers residing in very high poverty census tracts were more likely to be diagnosed with Hep B and C.
The Health Department today released a new report detailing the city’s hepatitis B and C surveillance, research, and programmatic activities in 2014.
Jade: Song of Hope is a short documentary film produced by Hep Free Hawai’i and local filmmaker, Alex Bocchieri, to raise awareness about hepatitis C.
Office of HIV/AIDS and Infectious Disease Policy (OHAIDP) released a meeting report from the Technical Consultation on the Elimination of Perinatal Hepatitis B in the U.S held in Washington DC
The objective of this study was to assess the cost-effectiveness of (1) treating all patients with HCV vs only those with advanced fibrosis and (2) treating each stage of fibrosis.
NYS Department of Health recommends hepatitis C (HCV) reflex RNA testing implementation to improve HCV diagnosis and linkage to care rates.
The New York State Department of Health has made available new sexual health infographic postcards, including this one on Hep C “Getting Inked or Pierced? 4 Ways to Prevent Hepatitis C.”
The study suggest that PWID with higher internalized stigma are less likely to consistently use sterile syringe sources in urban settings with multiple sterile syringe access points.
The Hep B: The Facts booklet has a fresh new look and enhanced information about Hep B.
In “Take Care, Take Charge” you can find practical tips for safer use, where to get new syringes, how to prevent an overdose, information on HIV and Hep C, and more.
This is the first video in the series “Young People Who Inject” developed by Harm Reduction Coalition in partnership with the New York State Department of Health.
Find practical tips for preventing overdose, Hep C and HIV and information on local resources.
The City Health Information (CHI) publication is an evidence-based clinical bulletin for health care providers throughout New York City. The “Preventing Injection-associated Infections in Outpatient Settings” CHI was written to improve patient safety by highlighting unsafe injection practices that increase the risk of infections. The CHI will cover epidemiology of injection-associated infections in the city, … Continue reading CME/CNE | Preventing Injection-Associated Infections (NYC Health Dept)
Journal of General Internal Medicine, July 2015 Many of the five million Americans chronically infected with hepatitis C (HCV) are unaware of their infection and are not in care. OBJECTIVE: We implemented and evaluated HCV screening and linkage-to-care interventions in a community setting. DESIGN: We developed a comprehensive, community-based HCV screening and linkage-to-care program in … Continue reading Article | Results from a Geographically Focused, Community-Based Hep C Screening, Linkage-to-Care & Patient Navigation Program
Journal of Hepatology, August 2015 Revolutionary new drugs to cure hepatitis C virus (HCV) infection represent one of the most important breakthroughs in clinical medicine in recent decades. However, high pricing of these well-tolerated, highly efficacious all-oral regimens and high demand (actual or anticipated) has led many payers in the United States and other countries … Continue reading Article | Excluding People Who Use Drugs or Alcohol from Access to Hep C Treatment – Is This Fair, Given the Available Data?
This free booklet is an educational resource for incarcerated people.
View in PubMed | View full article in PDF In high income countries, the majority of new and existing hepatitis C virus (HCV) infections occur among people who inject drugs (PWID). In many low and middle income countries large HCV epidemics have also emerged among PWID populations. The burden of HCV-related liver disease among PWID is increasing, but … Continue reading Article | Recommendations for Management of Hep C among People Who Inject Drugs (International Journal of Drug Policy, 2015)
“Hepatitis C treatment turned me around:” Psychological and behavioral transformation related to hepatitis C treatment. Drug and Alcohol Dependence, 2015. Abstract BACKGROUND: Hepatitis C (HCV) is a significant public health problem that primarily affects current and former substance users. However, individuals with a history of substance use are less likely to have access to or … Continue reading Article | Hep C treatment turned me around: Psychological & Behavioral Transformation Related to Hep C Treatment
The NYC Liver Health mobile app was developed in 2014 by the NYC Health Department to provide hepatitis B and hepatitis C screening, care and treatment information and health care access tools to patients and providers.
Alcohol use significantly increases the risk for developing fibrosis, cirrhosis, and liver cancer in people living with hepatitis. New Health Dept materials provide guidance in screening patients with hepatitis for alcohol use and steps to take to reduce risk.
DRUGS, DIAGNOSTICS, VACCINES, PREVENTIVE TECHNOLOGIES, RESEARCH TOWARD A CURE, & IMMUNE-BASED & GENE THERAPIES IN DEVELOPMENT JULY 17, 2015 WWW.PIPELINEREPORT.ORG Download PDFs Read online In this year’s report: Dedications The Antiretroviral Pipeline Fit for Purpose: Treatment Optimization The Pediatric Antiretroviral Pipeline Preventive Technologies: Antiretroviral and Vaccine Development Research Toward a Cure and Immune-Based and Gene … Continue reading 2015 HIV, HCV & TB Pipeline Report (Treatment Action Group)
Overview of Viral Hepatitis Surveillance, Prevention and Control activities at the NYC Department of Health and Mental Hygiene in 2013: Hep B and C Activities Report (pdf) The New York City Department of Health and Mental Hygiene has been actively engaged in hepatitis surveillance, prevention and control for over a decade; however, 2013 marked a year of … Continue reading NYC Health Dept Hep B & C Annual Report of Activities (2013)
Hepatitis B Birth Dose Coverage by NYC Facility, 2013 Hepatitis B Birth Dose Coverage by NYC Facility, 2012 Percent of infants who received hepatitis B vaccine within 3 days of birth by delivery facility, NYC. Published by the NYC Health Department, 2015. More info here. Hep Free NYC supports the Immunization Action Coalition’s National Hep … Continue reading Report | Hep B Birth Dose Coverage by NYC Facility (NYC Dept of Health, 2015)
Journal of Sexually Transmitted Diseases, 2015 See full article: Factors Associated With HCV Infection Among HIV-Infected MSM With No Reported Injection Drug Use, NY (2000-2010) (pdf) Background: Hepatitis C (HCV) infection is a major source of morbidity and mortality among HIV-infected patients. Despite decreasing HCV incidence in the United States, the proportion of cases among men who have sex with … Continue reading Article | Factors Associated With HCV Infection Among HIV-Infected MSM With No Reported Injection Drug Use, NY (2000-2010). Journal of Sexually Transmitted Diseases, 2015
Source: Defining the Experienced Hepatitis C Provider, New York State Department of Health AIDS Institute, June 2015 Transformative new treatments for hepatitis C virus (HCV) will greatly expand the number of patients in New York State who can be treated successfully. This expansion promises to reduce morbidity, mortality, and the incidence of HCV transmission, but it … Continue reading NYS Department of Health Defines HCV Experienced Provider
Unintentional Drug Poisoning (Overdose) Deaths Involving Opioids in New York City, 2000-2013 Data Brief (PDF) – Data Tables (PDF) August 2014, No. 50 (Updated) Health Department’s Bureau of Vital Statistics/Office of the Chief Medical Examiner 2000-2013
The NYC Health Department recently released the City Health Information (CHI): Diagnosing & Managing Hep C providing guidance to Primary Care Providers in hepatitis C screening, management and treatment.
Abstracts, Presentations, and Posters are now Available Online Abstracts, presentations, and posters from the 2015 National Summit on HCV and HIV Diagnosis, Prevention and Access to Care are available on the Summit webpage. Final Program and Abstract Book (PDF) Program Overview and Plenary Presentations Breakout Session Presentations Posters More information on the 2015 National Summit is available at http://www.hivforum.org/2015Summit … Continue reading 2015 National Summit on HCV & HIV Diagnosis, Prevention & Access to Care: Abstracts, Presentations & Posters
Dear Colleague: I am delighted to present the new National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention: Strategic Plan through 2020. This Plan updates the Center’s current strategic plan and serves as a blueprint for achieving our vision of a future free of HIV, viral hepatitis, STDs, and TB. It will guide activities … Continue reading CDC Viral Hepatitis Strategic Plan – 2020
Medicaid and Hepatitis C Treatment Access. The Center for Health Law and Policy Innovation (CHLPI) at Harvard Law School recently released a report that analyzes hepatitis C treatment access in Medicaid fee-for-service and managed care programs in 10 states (including NYC). It also provides information about how advocates can use the report to advocate for … Continue reading Report on Medicaid & Hep C Treatment Access (Center for Health Law & Policy Innovation)
Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013. Drug Alcohol Depend, 2015. HCV prevalence among PWID (N:1535) was 67% during the study period, and was not significantly different from that observed in 2000-2001. The estimated HCV incidence among new injectors (persons injecting for ≤6 years) … Continue reading Article | Incidence & prevalence of HCV among persons who inject drugs in NYC: 2006-2013. Drug Alcohol Depend, 2015.
Beyond Viral Response: a prospective evaluation of a community-based, multi-disciplinary, peer-driven model of HCV treatment and support. International Journal of Drug Policy, 2015. Highlights We prospectively study a community-based hepatitis C (HCV) treatment program serving active drug users in Toronto, Canada. We examine HCV care outcomes and changes in psycho-social status, including social determinants of health … Continue reading Article | A prospective evaluation of a community-based, multi-disciplinary, peer-driven model of Hep C treatment and support
Provider Reporting: How to Report Diseases, Events, and Conditions to the New York City Health Department. The Guide provides a Table of all reportable diseases, and events including instructions on how and when they should be reported. The Guide is currently available on-line at http://www.nyc.gov/html/doh/downloads/pdf/hcp/reporting-guide.pdf. Please share with your colleagues and email Molly Kratz (email@example.com) … Continue reading Provider Reporting | How to Report Diseases, Events & Conditions to the NYC Health Dept
An international perspective on using opioid substitution treatment (OST) to improve hepatitis C prevention and care for people who inject drugs: structural barriers and public health potential. International Journal of Drug Policy, 2015. Highlights We examined the use of mediation assisted treatment of opioid dependence to improve the HCV control. The stigmatization of drug use is … Continue reading Article | An international perspective on using opioid substitution treatment (OST) to improve hep C prevention & care for people who inject drugs
Take advantage of these free Hep B and Hep C educational resources from the NYC Health Department.
Treatment Action Group (TAG) is an independent AIDS research and policy think tank fighting for better treatment, a vaccine, and a cure for AIDS. Read TAG’s 2014 Annual Report for program updates and news, including their HIV/Hepatitis Project update and plan: TAG’s Hepatitis/HIV Project draws from the core values and history of AIDS activism to end hepatitis C. … Continue reading 2014 Annual Report – Hep C (Treatment Action Group)
In an effort to assist patients, clinics, and providers in obtaining coverage for HCV testing, The AIDS Institute is releasing an updated Coverage Guide for Hepatitis C Screening. The guide explains coverage of preventive services under the ACA and sets out specific coverage for HCV testing under various types of insurance, including private health plans, … Continue reading Hep C Testing Coverage Guide (The AIDS Institute)
A new study demonstrates that a multi-disciplinary, community-based model of HCV treatment improves participant’s lives in ways that extend beyond Hepatitis C. Researchers from the University of Toronto worked with the Toronto Community Hep C Program to examine HCV care outcomes and changes in psycho-social-economic status, including social determinants of health and measures of well-being. … Continue reading Article | Study Shows Improved Socio-economic Outcomes After Community-based HCV Treatment Program
This is an official CDC HEALTH ADVISORY Distributed via the CDC Health Alert Network April 24, 2015, 11:00 ET (11:00 AM ET) CDCHAN-00377 Summary The Indiana State Department of Health (ISDH) and the Centers for Disease Control and Prevention (CDC) are investigating a large outbreak of recent human immunodeficiency virus (HIV) infections among persons who inject drugs (PWID). … Continue reading CDC | Outbreak of HIV/HCV in Prescription Med Injectors (Indiana)
The CDC developed a new fact sheet on Hep C and injection drug use, including Hep C symptoms, testing, transmission, prevention, treatment, and reinfection.
The World Health Organization (WHO) issued its first-ever guidance for the treatment of chronic hepatitis B. Worldwide, some 240 million people have chronic hepatitis B virus with the highest rates of infection in Africa and Asia. People with chronic hepatitis B infection are at increased risk of dying from cirrhosis and liver cancer. Key recommendations include: … Continue reading World Health Organization Issues 1st Hep B Treatment Guidelines
The NYC Department of Health now offers a text messaging service for liver health and hepatitis linkage to care.
The NYC Health Department produced a public service announcement encouraging Hep C testing and treatment.
The NYC Department of Health produced a public service announcement encouraging hepatitis B screening and vaccination. The PSA is in English, Spanish and Chinese.
This webinar covers the most important elements that patients need to know regarding screening, access to care, receiving and paying for treatment, and living with hepatitis C.
To view the full NYC Hepatitis B and C Surveillance Report click here See also NYC Health Department Online Data Portal EpiQuery. Click here
The CDC’s Division of Viral Hepatitis (CDC DVH) has updated educational materials and video PSAs for the national Know More Hepatitis campaign.
The New York State Department of Health has published two new posters targeting Hep C testing for baby boomers.
Between 2009 and 2013, 4811 persons 30 and younger were newly reported to the NYC Health Department with hepatitis C.
2014 NYC HEP Health Care Access Training Report View full meeting report here Agenda & Handout:_2014 NYC Hep Health Care Access Training (PDF) Presentations Nirah Johnson, NYC DOHMH, Viral Hepatitis Health Care Access Resources (PDF slides) An overview of the state of hep B and C in NYC, NYS laws regarding hep B and C, free printed education materials from NYC DOHMH (call … Continue reading 2014 NYC HEP Health Care Access Training Report
Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000-2010. Epidemiol Infect. 2014 Nov. Bushnell G, Stennis NL, Drobnik AM, Proops DC, Ahuja SD, Bornschlegel K, Fuld J. Abstract SUMMARY Literature surrounding the burden of and factors associated with hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in … Continue reading Article | TB & Viral Hepatitis, New York City, 2000–2010
An evaluation of duplicate Hep C antibody testing conducted by NYC Department of Health staff has been published in the latest issue of Public Health Reports, Volume 129, Number 6, November/December 2014. ABSTRACT Repeating a hepatitis C virus antibody test for a person who previously tested positive provides no new information, wastes resources, and may reflect poor … Continue reading Article | Duplicate Hep C Antibody Testing in NYC (NYC Health Dept)
The American Liver Foundation (ALF) has announced a special educational campaign commemorating October as Liver Cancer Awareness Month.
Overview: CMS has finalized its decision to reimburse for HCV screening in primary care settings, for individuals who are Medicare eligible and either “high risk” or born between 1945-1965. “High risk” is defined as persons with a current or past history of illicit injection drug use; and persons who have a history of receiving a blood transfusion … Continue reading Medicare Guidelines | HCV screening for baby boomer & at risk beneficiaries
New! NYC Department of Health City Health Information (CHI) on Hep C 2014 The Diagnosing and Managing Hepatitis C CHI provides a thorough summary of risk assessment, testing recommendations, laboratory tests, and managing current HCV infection. There is specific information on how providers should speak to patients currently infected with HCV, as well as tables detailing common HCV … Continue reading New! Hep C CHI: NYC Health Dept Publication for Medical Providers
The Albert Einstein College of Medicine Division of Substance of Abuse invites you to the Bronx Premiere of “The Fix”!
Family Promise: Get Tested for Hepatitis B Video by CDC & Hep B United
The U.S. Preventative Services Task Force has updated their 2004 recommendation on hepatitis B screening and now recommends screening for hepatitis B virus (HBV) in non-pregnant adolescents and adults at high risk for infection, which may include: Those born in countries where the prevalence of HBV infection is 2% or greater Those born in the … Continue reading USPSTF Recommends Hep B Screening in High Risk Individuals
In recognition of Hepatitis Testing Day, May 19, The AIDS Institute has released a Hepatitis C (HCV) Testing Coverage Guide to assist health care providers with navigating each of the major healthcare payers’ coverage options for preventive services, specifically for HCV screening. Additionally, the guide will help educate people on the need to get tested … Continue reading AIDS Institute Releases Hep C Testing Coverage Guide
Watch the new Hep C Testing Law Video Developed by the NYS DOH Clinical Education Initiative (July 2015) Background on the Law Effective January 1, 2014, the NYS Hepatitis C Testing Law. 2171 requires healthcare providers to offer hep C test to baby boomers. The law requires full diagnostic testing for those who screen anti-body positive and either … Continue reading NYS Hep C ‘Baby Boomer’ Testing Law
Nirav R. Shah, M.D., the Commissioner of the New York State Health Department has released a Dear Colleague letter announcing the new Hepatitis C Testing Law. (Section 2171) The new law, which will take effect January 1st, 2014, mandates that every individual born between 1945 and 1965 be offered a Hepatitis C screening in either … Continue reading NYS COH Sends Dear Colleague Letter on Hep C Testing Law
Interagency Implementation Progress Report: HHS Action Plan for the Prevention, Care and Treatment of Viral Hepatitis. Dear Colleagues – I am very pleased to share a new report that features 2012 highlights of federal efforts to implement the Action Plan for the Prevention, Care and Treatment of Viral Hepatitis. Released in May 2011, the Action Plan details goals, strategies, … Continue reading HHS Releases Action Plan for the Prevention, Care & Treatment of Viral Hepatitis Progress Report
From PRN Press Release: November 5th 2013. The National Medical Association (NMA) released the much anticipated Consensus Panel Paper entitled: Hepatitis C: A Crisis in the African American Community. The NMA is the nation’s largest and oldest association of African American physicians and when faced with the startling facts on the burden of Hepatitis C … Continue reading Hep C in African Americans: Findings & Recommendations. National Medical Association Peer Reviewed Consensus Paper
Causes of Death among People with Hepatitis C in NYC, 2000‐2011. Jessie Pinchoff, PhD Candidate, MPH, Ann Drobnik, MPH, Jennifer Fuld, PhD Candidate, MA, Katherine Bornschlegel, Sarah L. Braunstein PhD, Jay K. Varma, MD. Division of Disease Control, New York City Department of Health and Mental Hygiene (NYC DOHMH) Poster: ID Week 2013 Conference Click … Continue reading Article | Causes of Death among People with Hepatitis C in NYC, 2000‐2011
HIV/Hepatitis C (HCV) Co‐infection among Men who have Sex with Men (MSM) in New York City (NYC), 2000‐2010. Ann Drobnik, MPH, Jessie Pinchoff, PhD Candidate, MPH, Jennifer Fuld, PhD Candidate, MA, Katherine Bornschlegel, Jay K. Varma, MD, Sarah L. Braunstein, PhD. Division of Disease Control, New York City Department of Health and Mental Hygiene (NYC … Continue reading Article | HIV/Hep C among Men who have Sex with Men in NYC, 2000‐2010 (NYC Health Dept)
TOP NEWS Health Department Announces Plan to Combat Hepatitis C The NYC Health Department today released the City’s first-ever plan for reducing illness and death from the hepatitis C virus (HCV), a disease that now accounts for more annual deaths nationwide than HIV/AIDS. In Hepatitis C in New York City: State of the Epidemic and Action … Continue reading NYC Health Department Announces Strategic Plan to Combat Hepatitis C
Watch this great video on hepatitis vaccination developed by Callen-Lorde TV
View as PDF: Dear Colleague COH-Hep C Screening 2013 April 2013 Dear Colleague: I am writing to ask your help with diagnosing and treating hepatitis C, an increasing cause of illness and death among New Yorkers. Across the nation, hepatitis C virus (HCV) now causes more deaths annually than HIV infection. Because new drug regimens … Continue reading Hep C Screening: NYC Commissioner of Health Dear Colleague Letter (April 2013)
See report displaying disease co-occurrence of HIV/AIDS, Hepatitis, STDs and Tuberculosis in NYC neighborhoods.
This special double-issue of Harm Reduction Communication has two central themes: hepatitis C (HCV) and personal narrative.. There are articles on: taking HCV prevention to a new level beyond syringe-only messaging, HCV counseling, testing and referral, HCV treatment stories, group HCV treatment models, HCV advocacy, HCV and domestic violence, remembering Michael Carden, impersonality and drug … Continue reading Harm Reduction Communication – Issue 17 – Fall 2012
In this old school rap video join Lady Hep A, The Notorious HBV, Funk Master C and Mistress CL Smooth as they school you on some basic Hepatitis knowledge. Get a glimpse of the ABCs of Hepatitis.
Watch this “Blood to Blood” video describing how young people can protect themselves from Hep C.